These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 23670818)
1. Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease. Marlatt MW; Potter MC; Bayer TA; van Praag H; Lucassen PJ Curr Top Behav Neurosci; 2013; 15():313-40. PubMed ID: 23670818 [TBL] [Abstract][Full Text] [Related]
2. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease. Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of exercise training against the progression of Alzheimer's disease in 3xTg-AD mice. Kim D; Cho J; Kang H Behav Brain Res; 2019 Nov; 374():112105. PubMed ID: 31325514 [TBL] [Abstract][Full Text] [Related]
4. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease. Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247 [TBL] [Abstract][Full Text] [Related]
5. Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease. Syal C; Kosaraju J; Hamilton L; Aumont A; Chu A; Sarma SN; Thomas J; Seegobin M; Dilworth FJ; He L; Wondisford FE; Zimmermann R; Parent M; Fernandes K; Wang J Theranostics; 2020; 10(14):6337-6360. PubMed ID: 32483456 [No Abstract] [Full Text] [Related]
6. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice. Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310 [TBL] [Abstract][Full Text] [Related]
7. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease. Li T; Jiao JJ; Hölscher C; Wu MN; Zhang J; Tong JQ; Dong XF; Qu XS; Cao Y; Cai HY; Su Q; Qi JS Hippocampus; 2018 May; 28(5):358-372. PubMed ID: 29473979 [TBL] [Abstract][Full Text] [Related]
8. Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice. Yan XD; Qu XS; Yin J; Qiao J; Zhang J; Qi JS; Wu MN J Alzheimers Dis; 2022; 85(1):343-357. PubMed ID: 34806605 [TBL] [Abstract][Full Text] [Related]
10. Fluoxetine delays the cognitive function decline and synaptic changes in a transgenic mouse model of early Alzheimer's disease. Zhou CN; Chao FL; Zhang Y; Jiang L; Zhang L; Fan JH; Wu YX; Dou XY; Tang Y J Comp Neurol; 2019 Jun; 527(8):1378-1387. PubMed ID: 30592045 [TBL] [Abstract][Full Text] [Related]
11. Stereological Investigation of the Effects of Treadmill Running Exercise on the Hippocampal Neurons in Middle-Aged APP/PS1 Transgenic Mice. Chao F; Jiang L; Zhang Y; Zhou C; Zhang L; Tang J; Liang X; Qi Y; Zhu Y; Ma J; Tang Y J Alzheimers Dis; 2018; 63(2):689-703. PubMed ID: 29689723 [TBL] [Abstract][Full Text] [Related]
12. Voluntary running and environmental enrichment restores impaired hippocampal neurogenesis in a triple transgenic mouse model of Alzheimer's disease. Rodríguez JJ; Noristani HN; Olabarria M; Fletcher J; Somerville TD; Yeh CY; Verkhratsky A Curr Alzheimer Res; 2011 Nov; 8(7):707-17. PubMed ID: 21453244 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background. Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269 [TBL] [Abstract][Full Text] [Related]
14. Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease. Ye M; Chung HS; An YH; Lim SJ; Choi W; Yu AR; Kim JS; Kang M; Cho S; Shim I; Bae H Mol Neurobiol; 2016 Oct; 53(8):5401-12. PubMed ID: 26446019 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Nelson RL; Guo Z; Halagappa VM; Pearson M; Gray AJ; Matsuoka Y; Brown M; Martin B; Iyun T; Maudsley S; Clark RF; Mattson MP Exp Neurol; 2007 May; 205(1):166-76. PubMed ID: 17368447 [TBL] [Abstract][Full Text] [Related]
16. A Comparative Study Evaluating the Impact of Physical Exercise on Disease Progression in a Mouse Model of Alzheimer's Disease. Maliszewska-Cyna E; Xhima K; Aubert I J Alzheimers Dis; 2016 May; 53(1):243-57. PubMed ID: 27163797 [TBL] [Abstract][Full Text] [Related]
17. Fluoxetine Protects against Dendritic Spine Loss in Middle-aged APPswe/PSEN1dE9 Double Transgenic Alzheimer's Disease Mice. Ma J; Gao Y; Tang W; Huang W; Tang Y Curr Alzheimer Res; 2020; 17(1):93-103. PubMed ID: 32053075 [TBL] [Abstract][Full Text] [Related]
18. Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise. Micheli L; Ceccarelli M; D'Andrea G; Tirone F Brain Res Bull; 2018 Oct; 143():181-193. PubMed ID: 30236533 [TBL] [Abstract][Full Text] [Related]
19. Microglial response to Alzheimer's disease is differentially modulated by voluntary wheel running and enriched environments. Rodríguez JJ; Noristani HN; Verkhratsky A Brain Struct Funct; 2015 Mar; 220(2):941-53. PubMed ID: 24374506 [TBL] [Abstract][Full Text] [Related]
20. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]